IP Library Patent Application 12097132
Patent Application
App. No. 12/097,132

Skin Care Compositions and Treatments

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/097,132
Abstract

The invention is directed compositions containing growth agents synthesized from cultured cells from skin. Skin cells such as keratinocytes and dermal fibroblasts are cultured in vitro in cell medium and in the course of culture the cultured cells synthesize and secrete agents into the cell medium. The medium containing agents are collected and incorporated into pharmaceutical or cosmetic preparations to treat an individual. The preparation is applied and has a rejuvenating effect on the cells and tissue.

Claims (33)

1 . A composition for use as a pharmaceutical preparation or as a skin care product comprising:

(a) a carrier base;

(b) a conditioned cell medium containing one or more cultured skin agents synthesized and secreted from cultured keratinocytes and fibroblasts; and,

(c) a penetration enhancer.

2 . The composition of claim 1 further comprising

an antioxidant.

3 . The composition of claim 1 , wherein the keratinocytes and fibroblasts are a co-culture in a bilayer configuration that resembles the native configuration of skin.

4 . (canceled)

5 . The composition of claim 3 , wherein the co-culture comprises fibroblasts in an endogenously produced matrix and keratinocytes disposed thereon.

6 - 8 . (canceled)

9 . The composition of claim 1 , wherein the penetration enhancer is selected from the group consisting of: a chemical penetration enhancer, an active penetration enhancer, or a follicular penetration enhancer.

10 . (canceled)

11 . A method for producing a preparation containing a conditioned cell medium containing one or more cultured skin agents produced by cultured skin cells, comprising:

(a) culturing skin cells in a nutrient containing medium to grow the skin cells and inducing skin cells to synthesize and secrete one or more cultured skin agents into the medium;

(b) separating the conditioned medium containing one or more cultured skin agents from the cultured skin cells;

(c) increasing the concentration of the cultured skin agents in the conditioned cell medium;

(d) reducing the salt concentration in the conditioned medium; and

(e) producing a preparation comprising the conditioned medium containing one or more cultured skin agents.

12 . The method of claim 11 , wherein the skin cells are keratinocytes and fibroblasts co-cultured in a bilayer configuration that resembles the native configuration of skin.

13 . (canceled)

14 . The method of claim 12 , wherein the bilayer configuration comprises fibroblasts in an endogenously produced matrix and keratinocytes disposed thereon.

15 - 17 . (canceled)

18 . The method of claim 11 , wherein the concentration of the cultured skin agents are increased between 5 and 30 times.

19 - 25 . (canceled)

26 . The method of claim 11 , wherein conditioned cell media is pre-filtered to remove cells and cell debris before concentration.

27 - 37 . (canceled)

38 . A skin treatment comprising a topically applied composition for increasing cell proliferation and decreasing cell senescence formulated with conditioned cell medium containing one or more cultured skin agents synthesized and secreted from cultured skin cells.

39 . The composition of claim 1 , wherein the penetration enhancer is a

silicone-based penetration enhancer.

40 . The composition of claim 39 , wherein the silicone-based penetration enhancer is selected from the group consisting of-cyclomethicone and dimethicone copolyol.

41 - 42 . (canceled)

43 . The composition of claim 1 , wherein the conditioned cell medium comprises components that are free of undefined animal organ or tissue extracts selected from the group consisting of: serum, pituitary extract, hypothalamic extract, placental extract, embryonic extract, and proteins and factors secreted by feeder cells.

44 . The method of claim 11 , wherein the nutrient containing medium comprises components that are free of undefined animal organ or tissue extracts selected from the group consisting of: serum, pituitary extract, hypothalamic extract, placental extract, embryonic extract, and proteins and factors secreted by feeder cells.

Assignments (5)
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT Recorded Aug 6, 2021
From: ORGANOGENESIS INC.
To: SILICON VALLEY BANK
Reel/Frame 057112/0677 →
SECURITY INTEREST Recorded Jun 19, 2018
From: ORGANOGENESIS INC.
To: SILICON VALLEY BANK
Reel/Frame 046392/0242 →
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2017
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: ORGANOGENESIS INC.
Reel/Frame 042072/0977 →
SECURITY AGREEMENT Recorded Sep 23, 2011
From: ORGANOGENESIS, INC.
To: WELLS FARGO BANK, N.A.
Reel/Frame 026954/0666 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2008
From: NIXON, ANDREW J.
To: ORGANOGENESIS, INC.
Reel/Frame 021906/0624 →